Showing results (11-20 of 47) with videos related to
Sort By:
Pageof 5
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 12, 2007
A protocol for generating high numbers of mature and functional human mast cells from peripheral bloodJ Lappalainen, K A Lindstedt, P T KovanenEuropean Journal of Pharmacology|October 10, 1989
Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neuronsM Koulu, B Sjöholm, J Lappalainen, et al.European Journal of Pharmacology|April 25, 1990
Effects of chronic SCH 23390 treatment on dopamine autoreceptor function in rat brainJ Lappalainen, J Hietala, B Sjöholm, et al.Psychopharmacology|January 1, 1992
Quantification of SCH 39166, a novel selective D1 dopamine receptor antagonist, in rat brain and bloodJ Hietala, T Seppäla, J Lappalainen, et al.Psychopharmacology|January 1, 1990
Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor bindingM Koulu, J Lappalainen, J Hietala, et al.European Journal of Pharmacology|October 18, 1988
Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleusM Koulu, J Lappalainen, U Pesonen, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Effects of acute administration of SCH 23390 on dopamine and serotonin turnover in major dopaminergic areas and mesencephalic raphe nuclei--comparison with ritanserinJ Lappalainen, J Hietala, M Koulu, et al.Neuroreport|October 1, 1990
5-HT3 receptor antagonist ondansetron does not alter effects of amphetamine on DA metabolismM Koulu, J Lappalainen, J Hietala, et al.European Journal of Neurology|May 18, 2012
Health-related quality of life and cost-effectiveness of treatment in subarachnoid haemorrhageK Malmivaara, S Juvela, J Hernesniemi, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 1, 1992
Chronic clozapine treatment down-regulates serotonin 5-HT-1c receptors in rat brainJ Hietala, M Koulu, M Kuoppamäki, et al.Pageof 5